Carmell Therapeutics Corporation (CTCX)

NASDAQ: CTCX · IEX Real-Time Price · USD

1.090

-0.080 (-6.84%)

At close: Jul 19, 2024, 4:00 PM

1.110

+0.020 (1.83%)

Pre-market: Jul 20, 2024, 9:28 AM EDT

Carmell Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	22	88	196	190
Market Cap Growth	-70.55%	-55.14%	3.09%	-
Enterprise Value	23	87	200	200
PE Ratio	-	-5.45	-20.41	-28.02
PS Ratio	1.02	-	-	-
PB Ratio	-42.46	3.55	-5.19	-6.43
P/FCF Ratio	-6.58	-10.50	-57.06	-160.61
P/OCF Ratio	-6.60	-10.53	-57.18	-161.60
EV/Sales Ratio	1.05	-	-	-
EV/EBITDA Ratio	-7.96	-6.03	-28.11	-36.20
EV/EBIT Ratio	-7.83	-5.97	-27.18	-34.68
EV/FCF Ratio	-6.65	-10.40	-58.11	-168.78
Debt / Equity Ratio	-1.11	0.09	-0.10	-0.33
Debt / EBITDA Ratio	-0.21	-0.15	-0.53	-1.75
Debt / FCF Ratio	-0.17	-0.25	-1.09	-8.18
Quick Ratio	0.13	0.08	0.02	0.00
Current Ratio	0.75	1.63	0.08	0.01
Asset Turnover	0.51	0	0	0
Interest Coverage	-24.90	-17.09	-4.31	-8.06
Return on Equity (ROE)	-71.00%	-1325.20%	71.00%	80.00%
Return on Assets (ROA)	-17.70%	-38.10%	-8.20%	-17.20%
Return on Capital (ROIC)	-810.55%	-22.11%	16.17%	9.76%
Earnings Yield	-34.23%	-18.33%	-4.90%	-3.57%
FCF Yield	-40.05%	-9.53%	-1.75%	-0.62%
Buyback Yield / Dilution	-1941.39%	-527.34%	92.41%	-
Total Shareholder Return	-1941.39%	-527.34%	92.41%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).